A Phase III, Randomized, Double-Blind, Parallel Group, Placebo Controlled, Multicenter Study to Assess the Efficacy and Safety of Mirabegron in Subjects With Symptoms of Overactive Bladder

The study is intended to test the efficacy, safety and tolerability of two doses of mirabegron against placebo to treat patients with symptoms of overactive bladder

本研究旨在评估两种剂量的米拉贝隆（mirabegron）对照安慰剂治疗伴有膀胱过度活动症（overactive bladder）症状患者的有效性、安全性与耐受性。